ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $292,000 | -74.3% | 4,867 | -63.9% | 0.01% | -73.1% |
Q2 2019 | $1,137,000 | -3.2% | 13,477 | +9.5% | 0.03% | -3.7% |
Q1 2019 | $1,175,000 | +34.9% | 12,303 | 0.0% | 0.03% | +28.6% |
Q4 2018 | $871,000 | -17.1% | 12,303 | 0.0% | 0.02% | -8.7% |
Q3 2018 | $1,051,000 | -26.3% | 12,303 | 0.0% | 0.02% | -32.4% |
Q2 2018 | $1,426,000 | +165.5% | 12,303 | +85.4% | 0.03% | +161.5% |
Q1 2018 | $537,000 | +38.0% | 6,635 | 0.0% | 0.01% | +44.4% |
Q4 2017 | $389,000 | -48.8% | 6,635 | -59.1% | 0.01% | -47.1% |
Q3 2017 | $760,000 | +30.1% | 16,233 | 0.0% | 0.02% | +30.8% |
Q2 2017 | $584,000 | -37.0% | 16,233 | -46.1% | 0.01% | -38.1% |
Q1 2017 | $927,000 | -8.0% | 30,099 | 0.0% | 0.02% | -8.7% |
Q4 2016 | $1,008,000 | +25.8% | 30,099 | 0.0% | 0.02% | +27.8% |
Q3 2016 | $801,000 | +107.5% | 30,099 | +129.3% | 0.02% | +100.0% |
Q1 2016 | $386,000 | -10.9% | 13,128 | 0.0% | 0.01% | -10.0% |
Q4 2015 | $433,000 | -8.6% | 13,128 | 0.0% | 0.01% | -16.7% |
Q3 2015 | $474,000 | -19.8% | 13,128 | 0.0% | 0.01% | -7.7% |
Q2 2015 | $591,000 | – | 13,128 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |